Treatment of Streptococcal Endocarditis With a Single Daily Dose of Ceftriaxone Sodium for 4 Weeks: Efficacy and Outpatient Treatment Feasibility

JAMA: The Journal of the American Medical Association

Volumn 267, Issue 2, 1992, Pages 264-267

  Francioli, Patrick ^a   Etienne, Jérôme ^b   Hoigné, Rolf ^c   Thys, Jean Pierre ^d   Gerber, Andreas ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b LOUIS PRADEL HOSPITAL   (France)

^c Service of Medicine ^*  (Switzerland)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BLOOD TOXICITY; CANDIDIASIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG SAFETY; DYSGEUSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CEFTRIAXONE; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS, BACTERIAL; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; LENGTH OF STAY; MALE; MIDDLE AGE; STREPTOCOCCAL INFECTIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0026565274     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03480020074034     Document Type: Article

References (23)

1. Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA. 1989;261:1471-1477.
2. Wilson WR, Geraci JE. Treatment of streptococcal infective endocarditis. Am J Med. 1985;78(suppl 6B):128-137.
3. Etienne J, Vandenesch F, Fauvel JP, et al. Susceptibilities to ceftriaxone of streptococcal strains associated with infective endocarditis. Chemotherapy. 1989;35:355-359.
4. Patel IH, Kaplan SA. Pharmacokinetic profile of ceftriaxone. Am J Med. 1984;77:17-25.
5. Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS. Ceftriaxone: a review of its antibacterial activity, pharmacological proprieties, and therapeutic use. Drugs. 1984;27:469-527.
6. Baumgartner JD, Glauser MP. Single daily dose treatment of severe refractory infections with ceftriaxone: cost savings and possible parenteral outpatient treatment. Arch Intern Med. 1984; 143:1868-1873.
7. Russo TA, Cook S, Gorbach SL. Intramuscular ceftriaxone in home parenteral therapy. Antimicrob Agents Chemother. 1988;32:1439-1440.
8. Bradley JS, Ching DK, Philips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J. 1988;7:160-164.
9. Von Reyn CF, Levy BS, Arbeit RD, et al. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981;94:505-518.
10. Wolfe JC, Johnson WD Jr. Penicillin-sensitive streptococcal endocarditis in vitro and clinical observations on penicillin-streptomycin therapy. Ann Intern Med. 1974;81:178-181.
11. Karchmer AW, Moellering RC, Maki DG, Swartz MN. Single-antibiotic therapy for streptococcal endocarditis. JAMA. 1979;241:1801-1806.
12. Malacoff RF, Frank E, Andriole VT. Streptococcal endocarditis (nonenterococcal, non-group A) single vs combination therapy. JAMA. 1979; 241:1807-1810.
13. Stamboulian D, Bonvehi P, Arevalo C, et al. Antiobiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis. 1991;13:(suppl 2)160-163.
14. Wilson WR, Thompson RL, Wilkowske CJ, et al. Short-term therapy for streptococcal infective endocarditis: combined intramuscular administration of penicillin and streptomycin. JAMA. 1981;245:360-363.
15. Olaison L, Alestig K. A prospective study of neutropenia induced by high doses of betalactam antibiotics. J Antimicrob Chemother. 1990;25:449-453.
16. Pfeifer JF, Lipton MJ, Oury JH, Angell WW, Hultgren HN. Case reports: acute coronary embolism complicating bacterial endocarditis: operative treatment. Am J Cardiol. 1976;37:920-922.
17. Greenberg BH, Hoffman P, Schiller NB, Miller M, Chatterjee K. Sudden death in infective endocarditis. Chest. 1977;71:794-795.
18. Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of bacterial endocarditis. Medicine. 1978;57:329-343.
19. Salgado AV, Furlan AJ, Keys TF, Nichols TR, Beck GJ. Neurologic complications of endocarditis: a 12-year experience. Neurology. 1989;39:173-178.
20. Paschalis C, Pugsley W, John E, Harrison MJG. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis. Eur Neurol. 1990; 30:87-89.
21. Jaffe WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis, 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol. 1990;15:1227-1233.
22. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size detemined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989; 14:631-638.
23. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1990; 264:2919-2922.